These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 29361840)

  • 1. Safety and Efficacy of OXB-202, a Genetically Engineered Tissue Therapy for the Prevention of Rejection in High-Risk Corneal Transplant Patients.
    Fouladi N; Parker M; Kennedy V; Binley K; McCloskey L; Loader J; Kelleher M; Mitrophanous KA; Stout JT; Ellis S
    Hum Gene Ther; 2018 Jun; 29(6):687-698. PubMed ID: 29361840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of neovascularization of donor corneas by transduction with equine infectious anemia virus-based lentiviral vectors expressing endostatin and angiostatin.
    Parker M; Bellec J; McFarland T; Scripps V; Appukuttan B; Hartzell M; Yeager A; Hady T; Mitrophanous KA; Stout T; Ellis S
    Hum Gene Ther; 2014 May; 25(5):408-18. PubMed ID: 24460027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corneal transduction to inhibit angiogenesis and graft failure.
    Murthy RC; McFarland TJ; Yoken J; Chen S; Barone C; Burke D; Zhang Y; Appukuttan B; Stout JT
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):1837-42. PubMed ID: 12714613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Standardized semiquantitative analysis of corneal neovascularization using projected corneal photographs--pilot study after perforating corneal keratoplasty before immune reaction].
    Cursiefen C; Wenkel H; Martus P; Langenbucher A; Seitz B; Küchle M
    Klin Monbl Augenheilkd; 2001 Jul; 218(7):484-91. PubMed ID: 11512248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a phosphorodiamidate morpholino oligomer antisense compound in the inhibition of corneal transplant rejection in a rat cornea transplant model.
    Hosseini A; Lattanzio FA; Samudre SS; DiSandro G; Sheppard JD; Williams PB
    J Ocul Pharmacol Ther; 2012 Apr; 28(2):194-201. PubMed ID: 22149555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of corneal allograft rejection by systemic cyclosporine-A in heavily vascularized rabbit corneas following alkali burns.
    Rehany U; Waisman M
    Cornea; 1994 Sep; 13(5):447-53. PubMed ID: 7995070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
    Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
    Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of interleukin-12p40 gene transfer on rat corneal allograft survival.
    Ritter T; Yang J; Dannowski H; Vogt K; Volk HD; Pleyer U
    Transpl Immunol; 2007 Nov; 18(2):101-7. PubMed ID: 18005852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corneal graft rejection.
    Panda A; Vanathi M; Kumar A; Dash Y; Priya S
    Surv Ophthalmol; 2007; 52(4):375-96. PubMed ID: 17574064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical transplantation of individualized recipient serum-adapted cornea reduces the risk of graft rejection after keratoplasty.
    Thanos S; Gatzioufas Z; Schallenberg M; König S; Meyer-Rüsenberg HW; Busse H
    Cell Transplant; 2013; 22(3):477-91. PubMed ID: 23043892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits.
    Shi W; Gao H; Xie L; Wang S
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3339-44. PubMed ID: 16877400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep anterior lamellar keratoplasty using acellular corneal tissue for prevention of allograft rejection in high-risk corneas.
    Li J; Yu L; Deng Z; Wang L; Sun L; Ma H; Chen W
    Am J Ophthalmol; 2011 Nov; 152(5):762-70.e3. PubMed ID: 21803324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sustained rapamycin drug delivery system in prevention of high risk corneal allograft rejection and neovascularization in rabbits].
    Gao H; Shi WY; Xie LX; Wang SG
    Zhonghua Yan Ke Za Zhi; 2006 Jan; 42(1):6-11. PubMed ID: 16638273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy approaches to prevent corneal graft rejection: where do we stand?
    Ritter T; Wilk M; Nosov M
    Ophthalmic Res; 2013; 50(3):135-40. PubMed ID: 23941996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental efficacy of mycophenolate mofetil implant on high-risk corneal allograft rejection and its biocompatibility in the anterior chamber of rabbits.
    Xin M; Wang T; Shi W; Wu X
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):609-17. PubMed ID: 22846154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Bone Derived Collagen for the Development of an Artificial Corneal Endothelial Graft. In Vivo Results in a Rabbit Model.
    Vázquez N; Chacón M; Rodríguez-Barrientos CA; Merayo-Lloves J; Naveiras M; Baamonde B; Alfonso JF; Zambrano-Andazol I; Riestra AC; Meana Á
    PLoS One; 2016; 11(12):e0167578. PubMed ID: 27907157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preincubation of donor tissue with a VEGF cytokine trap promotes subsequent high-risk corneal transplant survival.
    Zhang W; Schönberg A; Hamdorf M; Georgiev T; Cursiefen C; Bock F
    Br J Ophthalmol; 2022 Nov; 106(11):1617-1626. PubMed ID: 34810177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological disruption of antiangiogenic signals by recruited allospecific T cells leads to corneal allograft rejection.
    Tan Y; Cruz-Guilloty F; Medina-Mendez CA; Cutrufello NJ; Martinez RE; Urbieta M; Wilson D; Li Y; Perez VL
    J Immunol; 2012 Jun; 188(12):5962-9. PubMed ID: 22593618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rejection of corneal allografts].
    Guilbert E; Laroche L; Borderie V
    J Fr Ophtalmol; 2011 May; 34(5):331-48. PubMed ID: 21492957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor in a recipient cornea acts as a prognostic factor for corneal graft reaction development.
    Sekelj S; Dekaris I; Balog T; Mahovne I; Krstonijevic EK; Janjetovic Z; Arar ZV; Aric I
    Curr Eye Res; 2015 Apr; 40(4):407-14. PubMed ID: 24912114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.